Re: Nature's vs. Science's Embargo Policy

From: Alan Story <a.c.story_at_ukc.ac.uk>
Date: Mon, 13 Jan 2003 15:54:21 -0000

Jan:

Further on the question of open access by potential authors.

A few questions re: BioMed Central waivers ( of the $500 article-processing
charge);

a) What does BioMed consider a "low income country"....which may mean the
author from such a country may potentially have the fee waived? For example,
do you use the WTO's list of the 50 least developed countries?

b) What percentage of articles published in BioMed Central receive a full
($US500)waiver of the article processing charges? How many of such articles
have been from authors in low income countries?

c) Do you have a quota on how many full waivers can annually be granted and
how are such waivers financed by BioMed?

d) What, specifically, are the criteria used to waive charges, including
from low income countries?

Regards

Alan Story

-----Original Message-----
From: September 1998 American Scientist Forum
[mailto:AMERICAN-SCIENTIST-OPEN-ACCESS-FORUM_at_LISTSERVER.SIGMAXI.ORG]On Behalf Of Jan
Velterop
Sent: Friday 10 January 2003 17:36
To: AMERICAN-SCIENTIST-OPEN-ACCESS-FORUM_at_LISTSERVER.SIGMAXI.ORG
Subject: Re: Nature's vs. Science's Embargo Policy


BioMed Central waives charges for those who cannot stump up the $500 and
make a reasonable case for that.

Jan Velterop
Received on Mon Jan 13 2003 - 15:54:21 GMT